This inventor holds 2 USPTO granted patents. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 2003-2004.
Company Filing History:
Years Active: 2003-2004
Title: Innovations of Wan Jin Song in Antibacterial Agents
Introduction
Wan Jin Song is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of optically active compounds with antibacterial properties. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Wan Jin Song's latest patents focus on optically active quinoline carboxylic acid derivatives. These derivatives contain 7-pyrrolidine substituents that induce optical activity. The first patent describes a process for preparing these compounds, which include their pharmaceutically acceptable salts and solvates. The compounds exhibit superior antibacterial activity and pharmacokinetic profiles compared to their enantiomers and conventional antibacterial agents, with minimal phototoxicity. This makes them promising candidates for use as antibacterial agents.
Career Highlights
Wan Jin Song is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research has led to advancements in the development of effective antibacterial agents, showcasing his commitment to improving healthcare outcomes.
Collaborations
Wan Jin Song has collaborated with notable colleagues, including Chi Woo Lee and Jin Soo Lee. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Wan Jin Song's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a key inventor in the development of effective antibacterial agents. His work continues to pave the way for advancements in medical treatments.